Immunological methods for treating schizophrenia

Details Immunological methods for treating schizophrenia Immunological methods for treating schizophrenia

1989-05-01

1991-08-06

Rosen, Sam

Drug, bio-affecting and body treating compositions

Lymphokine

514810, 514812, 424 88, A61K 3900

Patent

active

050376454

ABSTRACT:
Immunoassays of psychoactive drugs including psychotomimetic drugs, narcotic drugs, and tetrahydrocannabinols and treatment methods based on the antigenic properties of protein conjugates of these drugs. These methods are based upon treating the psychoactive substances as haptens and utilizing their protein conjugates to produce antibodies to the psychoactive materials themselves. The immunoassay methods include both agglutination and agglutination-inhibition reactions. The treatment methods include treatment of both exogenous, administered drugs (such as cannabinols, LSD, heroin and morphine) and endogenous substances (such as N,N-Dimethyltryptamine and 5-Methoxy-N,N-Dimethyltryptamine, by active immunization and also passive immunization.

REFERENCES:
Uebelhack et al., Biomed Biochim Acta, vol. 42 (1983) pp. 1343-1346.
Strahilevitz et al., Biological Psychiatry, vol. 3 (Aug. 1971) pp. 227-236.
Ranadive et al., Canadian Journal of Biochemistry, vol. 45, (1967) pp. 1701-1710.
Goodfriend et al., Immunologic Methods in Steroid Determination (ed. Peron and Caldwell) (1970) pp. 15-39.
Neri et al., Endocrinology, vol. 74, (1964) pp. 593-598.
Lieberman et al., Recent Progress in Hormone Research, vol. 15, pp. 165-200 (1959).
Schmidt et al., American Heart Association, 41st Scientific Sessions, Abstracts (Nov. 1968) p. V1-174.
Schmidt et al., Journal of Clinical Investigation, vol. 50, (Apr. 1971) pp. 866-871, 1738-1744.
Schmidt et al., Journal of Clinical Investigation, vol. 48 (1969) pp. 74a-75a.
Spector, Sydney, Advances in Biochemical Psychopharmacology, (ed. Costa and Greengard) vol. 1, (1969) pp. 181-190.
Boyd, William C., Fundamentals of Immunology (4th edition, 1966) pp. 69-72.
Smith et al., American Heart Association, 44th Scientific Sessions, Abstracts, (Nov. 1971) Paper 125, p. II-41.
Ochs et al., Journal of Clinical Investigation, vol. 60, (Dec. 1977) pp. 1303-1313.
Tanimukai et al, in Recent Advances in Biological Psychiatry, vol. 10, pp. 6-15, (1968).
Narasimhachari et al., Biological Psychiatry, vol. 3, pp. 21-23, (1971).
Heath et al., Arch. Gen. Psychiat., vol. 16, pp. 1-33, (1967).
Frohman et al., Annals New York Academy of Sciences, pp. 439-447, (1962).
Friedhoff et al., Nature, vol. 194, pp. 897-898, (1962).
Strahilevitz et al., Biological Psychiatry, vol. 10, pp. 287-302, (1975).
McKenna et al., Neuropharmacology, vol. 29, pp. 193-198, (1990).
Bruinvels et al., Pharmacopsychiat., vol. 21, pp. 28-32, (1988).
Melchior et al., CRC Critical Reviews in Toxicology, pp. 313-315, (1982).
Walti et al., Schweiz. Med. Wschr., vol. 116, pp. 303-305, (1986).
Tandler et al., Histochemistry, vol. 85, pp. 67-72, (1986).

Affiliated with

Also associated with

Rating

Immunological methods for treating schizophrenia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunological methods for treating schizophrenia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunological methods for treating schizophrenia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1985830